Studies have shown that oxidative stress is increased in patients with amyloidosis [28,29], and in vitro studies have demonstrated that oxidative stress inhibits the initial rate and extent of amyloid fibril formation of wild-type as well as V30M transthyretin [30]. Here, TTR is linked to amyloidosis.